Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 7/20 | 0.43 |
| ▸ | PPARA | Q07869 | 7/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoin SCHEMBL28243914 | 0.94 | LMNA (0.60) | LMNACES2CES1MAPK1NAAA | |
| SCHEMBL4929020 | 0.91 | NAAA (0.48) | LMNACES2CES1MAPK1NAAA | |
| SCHEMBL8036710 | 0.89 | NAAA (0.50) | LMNACES2CES1NAAAPPARG | |
| SCHEMBL390944 | 0.88 | LMNA (0.53) | LMNACES2CES1MAPK1NAAA | |
| Benzene SCHEMBL28132336 | 0.88 | LMNA (0.53) | LMNACES2CES1MAPK1NAAA | |
| SCHEMBL11442123 | 0.88 | NAAA (0.52) | NAAAPPARGPPARA | |
| SCHEMBL15865140 | 0.88 | NAAA (0.52) | NAAAPPARGPPARA | |
| SCHEMBL11667549 | 0.88 | NAAA (0.52) | NAAAPPARGPPARA | |
| SCHEMBL8753695 | 0.88 | NAAA (0.52) | NAAAPPARGPPARA | |
| SCHEMBL8753904 | 0.88 | NAAA (0.52) | NAAAPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005915-B2 | High-stretch energy curable inks and method of use in heat transfer label applications | SUN CHEMICAL CORPORATION (US) | 2018-06-26 | — | — | US | claimed |
| EP-3257677-A1 | INKS OR COATINGS AND METHOD OF USE IN HEAT TRANSFER LABEL APPLICATIONS | Sun Chemical Corporation (US) | 2017-12-20 | — | — | EP | claimed |
| US-20160137857-A1 | HIGH-STRETCH ENERGY CURABLE INKS & METHOD OF USE IN HEAT TRANSFER LABEL APPLICATIONS | SUN CHEMICAL CORPORATION (US) | 2016-05-19 | — | — | US | claimed |
| US-9275560-B2 | High-stretch energy curable inks and method of use in heat transfer label applications | SUN CHEMICAL CORPORATION (US) | 2016-03-01 | — | — | US | claimed |
| US-20140220315-A1 | HIGH-STRETCH ENERGY CURABLE INKS & METHOD OF USE IN HEAT TRANSFER LABEL APPLICATIONS | SUN CHEMICAL CORPORATION (US) | 2014-08-07 | — | — | US | claimed |
| EP-2739481-A1 | HIGH-STRETCH ENERGY CURABLE INKS & METHOD OF USE IN HEAT TRANSFER LABEL APPLICATIONS | Sun Chemical Corporation (US) | 2014-06-11 | — | — | EP | claimed |
| WO-2013019821-A1 | HIGH-STRETCH ENERGY CURABLE INKS & METHOD OF USE IN HEAT TRANSFER LABEL APPLICATIONS | SUN CHEMICAL CORPORATION (US) | 2013-02-07 | — | — | WO | claimed |
| US-5093467-A | Increased molecular weight | TOSOH CORPORATION (JP) | 1992-03-03 | — | — | US | claimed |
| EP-0348189-A2 | Production of poly (arylene sulfide sulfone) | Tosoh Corporation (JP) | 1989-12-27 | — | — | EP | claimed |
| EP-4749682-A1 | CURABLE COMPOSITION, FILM FORMING METHOD, AND METHOD FOR PRODUCING ARTICLE | Canon Kabushiki Kaisha (JP) | 2026-05-27 | — | — | EP | disclosed |
| CN-122071546-A | Curable composition, film forming method, and method for producing product | 佳能株式会社 | 2026-05-22 | — | — | CN | disclosed |
| CN-114127585-B | Scintillator unit and radiation detector | 佳能株式会社 | 2026-05-22 | — | — | CN | disclosed |
| US-20260140445-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | CANON KK (JP) | 2026-05-21 | — | — | US | disclosed |
| US-12629718-B2 | Film forming method and article manufacturing method | CANON KABUSHIKI KAISHA (JP) | 2026-05-19 | — | — | US | disclosed |
| US-6211270-B1 | HEAT AND LIGHT STABILIZERS FOR POLYMERS | WITCO VINYL ADDITIVES GMBH (DE) | 2001-04-03 | — | — | US | disclosed |
| US-6174941-B1 | FOR STABILIZING CHLORINE CONTAINING POLYMERS SUCH AS POLYVINYL CHLORIDE | WITCO VINYL ADDITIVES GMBH (DE) | 2001-01-16 | — | — | US | disclosed |
| US-6156830-A | 5-substituted 6-aminouracils as stabilizers for halogenated polymers | WITCO VINYL ADDITIVES GMBH (DE) | 2000-12-05 | — | — | US | disclosed |
| US-6084013-A | MIXTURES OF SUBSTITUTED URACILS OR THIURACILS WITH ALUMINUM CALCIUM HYDROXIDES, PHOSPHITES AND CARBONATES OR THEIR HYDRATES, ALSO LITHIUM LAYERED LATTICE COMPOUNDS AND TITANIUM HYDROTALCITES, FOR POLYVINYL CHLORIDE | WITCO VINYL ADDITIVES GMBH (DE) | 2000-07-04 | — | — | US | disclosed |
| US-5025036-A | Antiinflammatory agents, gastrointestinal, cardiovascular and skin disorders | HOFFMANN-LA ROCHE INC. (US) | 1991-06-18 | — | — | US | disclosed |
| EP-0401503-A2 | Solid non-hygroscopic trialkylamine oxides | ALBEMARLE CORPORATION (US) | 1990-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629718-B2 | Film forming method and article manufacturing method | AUP1, VCL, RHOA | LMNA 899/4885CES2 2081/4885CES1 2707/4885 |
| US-20260140445-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | CFL1, ATM, PSPC1 | LMNA 1691/4885CES2 3618/4885CES1 2903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.